There is a greatly increased interest in Herpesvirus hominis infections especially those of type 2 associated with genital lesions or neonatal disease. Physicians are eager to confirm the clinical impression with a specific virologic diagnosis such as isolation of the agent and its typing, and type-specific antibody responses. Procedures are reviewed here which permit such studies in general microbiology laboratories equipped for simple cell culture and immunofluorescence. This paper recounts experience with several laboratory methods and evaluates their efficiency and practicability in a general laboratory. Virus isolation was optimal if specimens were obtained from visible lesions early in their evolution and it often provided a specific diagnosis, including typing of the isolate by immunofluorescence, within 24 to 48 h. Estimation of serum antibodies to herpes simplex virus type 1 and 2 by indirect immunofluorescence was more sensitive and perhaps also more specific than by microneutralization test. A pilot study of herpes simplex virus antibody titers in mothers and in the cord blood of the offspring suggested the need to evaluate a possible protective role of high titer antibody in the fetus.
During the past decade, there has been a steady increase in the interest in specific laboratory diagnosis of herpesvirus infections in general hospitals. Some major reasons for this development may be found in the following: (i) an apparent substantial increase in Herpesvirus hominis (herpes simplex virus [HSV]) type 2 infections, perhaps as a part of the current epidemic of venereal disease; (ii) concern about disseminated neonatal herpes acquired from maternal virus-containing lesions before, or at, term; (iii) recognition that disseminated herpes occurs as a severe complication in drug-induced immunosuppression; (iv) the development of treatment modalities for local herpetic lesions (eye, skin, mucous membranes) and the possibility that serious systemic infection with herpes viruses may be susceptible to therapy in the future.
In general, clinicians are interested in the following specific questions. Can virus be isolated from a lesion, confirming a clinical impression? What type of herpesvirus is present, i.e., is it H. hominis type 1 6 ml. Small drops (approximately 0.02 ml) of this cell suspension were placed within the etched circles of microscope slides, with PH strain on one side and MS on the other. Slides were dried at 35 C, fixed in cold acetone for 15 min, rinsed in phosphate-buffered saline, pH 7.2, air-dried, and stored at -20 C. Serum dilutions, prepared as described above or in phosphate-buffered saline, were added to both circles. The slides were incubated in moist chambers at 35 C for 30 min, rinsed in phosphate-buffered saline for 15 min with occasional shaking, and air-dried. A 1:150 dilution in saline of a commercial (BBL) fluorescein-conjugated antihuman globulin was then added to each spot, and the slides were incubated and rinsed as before, and mounted in buffered glycerol saline. The titer of the serum was defined as the highest dilution of serum resulting in 3+ to 4+ fluorescence of infected cells, with less than 1 + fluorescence of the uninfected cells in the same field.
Immunofluorescence typing of isolates. Isolates were typed after one or two passages in cells. When 50 to 100% of Vero cells in tube monolayers showed typical CPE, the cells were harvested as described above and pooled with similarly treated cells from three tubes of uninfected cells. Drops of this cell suspension mixture were placed within two etched circles on several slides. After fixation, the slides were stored at -20 C. To Geometric mean titers of sera tested against HSV type 1 and 2 antigens are given in Table 1 . In all instances, the mean titer against HSV type 1 Table 2 . It has been shown that specific neutralizing antibodies to herpesviruses have similar titers in mother and offspring, if the infection (clini-cally apparent or latent) has been present for some time in the mother (5, 10) . It is possible that a substantial titer of antibodies in the fetus, present at the time of potential exposure to HSV type 2, has some protective effect against the initial virus reinfection. Two babies ( Table 2) had such antibodies, and normal delivery (without cesarean section) was not followed by evidence of herpes infection, although virus-containing lesions had been observed in the mothers' genital tracts less than 8 to 30 days before delivery. This question merits further investigation to avoid unnecessary cesarean sections.
